Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Withdrawn 1Terminated 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Fallopian Tube Neoplasms 9Ovarian Neoplasms 8Uterine Cervical Neoplasms 6Pancreatic Neoplasms 4Brenner Tumor 4Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Thymoma 2Testicular Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Salivary Gland Neoplasms 2Oropharyngeal Neoplasms 2Neurotoxicity Syndromes 2Mouth Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2HIV Infections 2Esophageal Neoplasms 2Endometrial Clear Cell Adenocarcinoma 2Endometrial Adenocarcinoma 2Carcinoma, Ovarian Epithelial 2Anus Neoplasms 2Anatomic Stage I Breast Cancer AJCC v8 2Urinary Bladder Neoplasms 1Teratoma, Testicular 1Teratoma, Ovarian 1Teratoma 1Sertoli-Leydig Cell Tumor 1

Interventions

Polymerase Chain Reaction 5Watchful Waiting 2Taxes 2Paclitaxel 2Light Coagulation 2Imiquimod 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Gene Expression Profiling 2Fluorouracil 2Flow Cytometry 2Etoposide 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Biopsy 2nirogacestat 1fludarabine 1emvododstat 1carmustine, poliferprosan 20 drug combination 1axicabtagene ciloleucel 1Vorinostat 1Vincristine 1Vinblastine 1Sodium Chloride 1Smoking Devices 1Restraint, Physical 1Remote Patient Monitoring 1Radiotherapy 1Radiation 1Procarbazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × HIV Infections × Taxes × Clear all
NCT03834571 2022-06-21

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

AIDS Malignancy Consortium

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Neoplasms, HIV Infections

NCT01249443 2020-07-29

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

AIDS Malignancy Consortium

Phase 1 Terminated
17 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Anus Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡